News

Eli Lilly Korea has introduced Ebglyss, a new biologic therapy designed to treat moderate-to-severe atopic dermatitis. The treatment, which comes...

Psoriasis, a systemic condition often viewed solely from a dermatological lens, is associated with various comorbidities, including metabolic syndrome, heart...

Biocon's stock surged by 8.5% on Tuesday, January 7, reaching ₹389 per share, a level not seen since mid-September. The...

L'Oréal Groupe has launched a new device designed to revolutionize skin care by providing consumers with a personalized analysis in...

Infants with atopic dermatitis (AD) are at an increased risk for developing a sequence of allergic conditions, a phenomenon known...

Johnson & Johnson (J&J) has announced a new licensing agreement with Kaken Pharmaceutical to expand its pipeline for treating atopic...

A breakthrough in treating inflammatory skin conditions like eczema could be on the horizon, thanks to new research from American...

Researchers have identified a key predictor for the development of asthma in young children: the presence of eosinophilic inflammation in...

A groundbreaking skincare solution promises to reduce facial redness instantly and over time, targeting conditions like rosacea, eczema, and irritated...

The Inkey List has unveiled an innovation that it claims will redefine the hydration category: Ectoin Hydro-Barrier Serum. The product...